Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Michael K. Pitt"'
Autor:
Bethan Freestone, Kaeng W. Lee, A M Fawzy, Harkaran Kalkat, Sampath Athukorala, Jerome Ment, George Pulikal, Gurbir Bhatia, B H Loku Waduge, Abdullah Saif, Michael K. Pitt, Sandeep Basavarajaiah, Nitin Kumar
Publikováno v:
European Heart Journal. 42
Background Drug coated balloons (DCBs) in Europe are mainly used in restenotic lesions as endorsed by the European Society of Cardiology, with a class IA recommendation. However, some of the recent data suggest, it can also be considered in a subset
Autor:
Bethan Freestone, Abdullah Saif, Jerome Ment, Kaeng W. Lee, Michael K. Pitt, Harkaran Kalkat, B H Loku Waduge, Sandeep Basavarajaiah, S Athulorala, A M Fawzy, Gurbir Bhatia, George Pulikal, Nitin Kumar
Publikováno v:
European Heart Journal. 42
Aims The use of scoring balloon prior to drug coated balloon has been proven to be effective in restenotic lesions. However, their effect in de novo lesions has not been tested. Logic tells that the use of scoring balloons should enhance the drug upt
Use of sirolimus-coated balloon in de novo lesions; Mid-term follow-up from a single-centre registry
Autor:
Abdullah Saif, Bethan Freestone, Kaeng W. Lee, B H Loku Waduge, Nitin Kumar, George Pulikal, A M Fawzy, Harkaran Kalkat, S Athulorala, Jerome Ment, Michael K. Pitt, Sandeep Basavarajaiah, Gurbir Bhatia
Publikováno v:
European Heart Journal. 42
Introduction Use of drug coated balloons (DCBs) in coronary intervention is escalating and the guidelines recommend its use in restenotic lesions. However, recent data suggest it can also be considered in a subset of denovo lesions especially; small
Autor:
Sandeep Basavarajaiah, Jerome Ment, B H Loku Waduge, Nitin Kumar, Harkaran Kalkat, S Athulorala, Kaeng W. Lee, George Pulikal, Gurbir Bhatia, Abdullah Saif, Michael K. Pitt, Bethan Freestone, A M Fawzy
Publikováno v:
European Heart Journal. 42
Introduction Provisional stenting is the preferred strategy even in true bifurcations, however, to minimise the need for repeat revascularization of side-branches, the use of drug coated balloons has been suggested. Most of the data available in the
Autor:
George Pulikal, A M Fawzy, Sampath Athukorala, Bhagya Harindi Loku Waduge, Kaeng W. Lee, Bethan Freestone, Michael K. Pitt, Abdullah Saif, Gurbir Bhatia, Harkaran Kalkat, Jerome Ment, Sandeep Basavarajaiah, Nitin Kumar
Publikováno v:
Acute coronary syndromes & Interventional cardiology.
Background Drug coated balloons (DCBs) in Europe are mainly used in restenotic lesions as endorsed by the European Society of Cardiology, with a class IA recommendation. However, some of the recent data suggest, it can also be considered in a subset
Autor:
Sandeep Basavarajaiah, A M Fawzy, Sampath Athukorala, Abdullah Saif, Bhagya Harindi Loku Waduge, Kaeng W. Lee, George Pulikal, Harkaran Kalkat, Nitin Kumar, Bethan Freestone, Jerome Ment, Gurbir Bhatia, Michael K. Pitt
Publikováno v:
Acute coronary syndromes & Interventional cardiology.
Autor:
Sandeep Basavarajaiah, Sampath Athukorala, Gurbir Bhatia, A M Fawzy, Abdullah Saif, Bethan Freestone, Nitin Kumar, Jerome Ment, Bhagya Harindi Loku Waduge, Kaeng W. Lee, Michael K. Pitt, Harkaran Kalkat, George Pulikal
Publikováno v:
Acute coronary syndromes & Interventional cardiology.
Background The use of drug coated balloons (DCBs) in coronary intervention is escalating. There are two drugs of choice for coating either DCBs or drug eluting stents: Paclitaxel or Sirolimus. Most available DCBs are coated with Paclitaxcel, due to p
Autor:
Hannah Rides, Jerome Ment, Satoru Mitomo, Sunao Nakamura, Sandeep Basavarajaiah, Richard Watkin, Michael K. Pitt, Yusuke Watanabe, George Pulikal, Vinoda Sharma, Toru Ouchi, Ishaq Mohammed, Bethan Freestone, Gurbir Bhatia, Sampath Athukorala, Nitin Kumar, Kaeng W. Lee
Publikováno v:
International Journal of Cardiology. Heart & Vasculature
International Journal of Cardiology: Heart & Vasculature, Vol 34, Iss, Pp 100803-(2021)
International Journal of Cardiology: Heart & Vasculature, Vol 34, Iss, Pp 100803-(2021)
Highlights • Limited data on intra-stent CTO. • We explored the long-term outcomes in patients undergoing PCI to intra-stent CTO. • Acceptable rates of hard endpoints (cardiac death; 5.8%, TVMI; 4%). • High rates of TLR (45.6%). • PCI shoul
Autor:
Elena Vigano, Kaeng W. Lee, Richard Watkin, Beth Freestone, Sampath Athukorala, Jerome Ment, Sophia Khattak, Boyang Liu, Mohammed Ishaq, Michael K. Pitt, George Pulikal, Gurbir Bhatia
Publikováno v:
Acute Coronary Syndromes & Interventional Cardiology.
Introduction Bailout stenting post-Paclitaxcel drug coated balloon use (DCB) is done with Limus eluting stent as we don’t use Paclitaxcel eluting stent anymore. However, when using Sirolimus DCB, bailout stenting is done with Limus eluting stent, b
Autor:
Bernardo Cortese, Luca Testa, Rami Mokdad, Amir Aziz, Alfonso Lelasi, Sophia Khattak, Sandeep Basavarajaiah, Elena Vigano, Michael K. Pitt
Publikováno v:
Acute Coronary Syndromes & Interventional Cardiology.
Introduction Sub-optimal stent expansion due to coronary calcification augments the risk of restenosis and stent thrombosis. Calcium modification is generally achieved by rotational atherectomy or specialized balloons (scoring and cutting balloons),